+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Life Science Analytics - Global Strategic Business Report

  • PDF Icon

    Report

  • 193 Pages
  • May 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 4805616

Global Life Science Analytics Market to Reach $66.7 Billion by 2030

The global market for Life Science Analytics estimated at US$27.8 Billion in the year 2023, is projected to reach a revised size of US$66.7 Billion by 2030, growing at a CAGR of 13.3% over the analysis period 2023-2030. Life Science Analytics Services, one of the segments analyzed in the report, is expected to record 14% CAGR and reach US$40.1 Billion by the end of the analysis period. Growth in the Life Science Analytics Software segment is estimated at 12.2% CAGR for the next 7-year period.

The U.S. Market is Estimated at $8.3 Billion, While China is Forecast to Grow at 12.2% CAGR

The Life Science Analytics market in the U.S. is estimated at US$8.3 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$11.2 Billion by the year 2030 trailing a CAGR of 12.2% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 12.1% and 11.3% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 9.4% CAGR.

Report Features

  • Full access to influencer engagement stats
  • Free access to digital archives & research platform. The proprietary platform is fully enabled to unlock creativity and market knowledge of domain experts worldwide in a cohesive and collaborative manner. The state-of-art tools bring world class market perspectives while protecting participants` privacy and identity. Numbers, statistics and market narrative in the report are based on fully curated insights shared by domain experts and influencers in this space.
  • Opportunity to engage with interactive questionnaires that come with real-time data simulator tools & bespoke report generation capabilities
  • Full client access to peer collaborative and interactive platform for cross-enterprise smart exchange of ideas
  • Complimentary report updates for one year
  • Competitor coverage with global market shares of major players
  • Player market presence analysis (Strong/Active/Niche/Trivial) across multiple geographies
  • Access to curated YouTube video transcripts of domain experts/influencer interviews, podcasts, press statements and event keynotes

What to Expect from the Global Economy in 2024

Edgy geopolitics, and economic instability caused by monetary policy tightening and ensuing higher interest rates will create a tumultuous landscape for 2024. Several factors will continue to exert pressure on the path to recovery including hostilities in the Middle East and increasingly common climate disasters. Among the risks, several positives are also taking shape such as growing signs of disinflation and easing of anxiety over stubborn inflation, supply chain normalization and price moderation despite volatility in energy costs. Elections across several G21 jurisdictions, notably in India and the United States, will have potential ramifications for capital flows and investment strategies. While India emerges as a compelling destination in the global investment landscape, U.S, based tech firms will continue to dominate, fueled by a dynamic ecosystem of talent and capital. Tech opportunities in Silicon Valley and beyond remain attractive for investors seeking high-growth prospects supported largely by a resilient albeit slowing domestic economy and conducive regulatory environment. Europe will continue to battle tight monetary policy and recession risks with U.K. having the most challenging outlook and running the greatest risk of recession in 2024. China remains a wild card with hope for growth in the country underpinned by government spending and improvements in consumer spending. The volatile environment will offer both opportunities and challenges for investors and businesses alike. Embracing volatility as a catalyst for growth together with agility and strategic foresight in navigating investment decisions will remain important for survival.

Select Competitors (Total 44 Featured):

  • Accenture PLC
  • Cognizant Technology Solutions Corporation
  • IBM Corporation
  • IQVIA
  • MaxisIT Inc.
  • Oracle Corporation
  • SAS Institute, Inc.
  • SCIO Health Analytics, an EXL company
  • TAKE Solutions
  • Wipro Ltd.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of COVID-19 Pandemic & Looming Global Recession
  • An Introduction to Life Science Analytics
  • Global Market Prospects & Outlook
  • Descriptive Analytics: The Largest Segment
  • Sales & Marketing Application Poised for High Growth
  • China & Asia-Pacific to Spearhead Future Market Growth
  • Life Science Analytics - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Technology Advancements Fuel Market Growth
  • Rising Relevance of Big Data Analytics to Improve Productivity in Life Science Industry
  • Analytics Solutions Find Increasing Adoption in Clinical Trials
  • Rise in Pharmaceutical R&D Spending to Boost Adoption of Analytics in Clinical Research Institutions
  • Pharmaceutical R&D Spending (in US$ Billion) for 2010-2020
  • Leading Pharmaceutical Companies Ranked by R&D Spending
  • AI, ML & Big Data Transform Clinical Trials Market
  • Increasing Prevalence of Chronic Diseases Boosts Market Prospects
  • Need to Curb Surging Healthcare Spending & Improve Patient Outcomes Enhance Importance of Analytics
  • Growing Use of Analytics in Personalized and Precision Medicine: A Major Growth Opportunity
  • Global Precision Medicine Market Size (US$ Billion) for the Years 2019, 2022 and 2025
  • Need for Better Data Standardization Spurs Need for Analytics Solutions in Life Science Industry
  • Rising Prominence of Value-Based Medicine Presents Opportunity for Market Growth
  • High Implementation Costs, Privacy Concerns & Workforce Shortage: Key Challenges for the Market
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Life Science Analytics Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • Table 2: World Recent Past, Current & Future Analysis for Life Science Analytics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 3: World 7-Year Perspective for Life Science Analytics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 5: World 7-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 6: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 7: World 7-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 8: World Recent Past, Current & Future Analysis for Descriptive Analytics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 9: World 7-Year Perspective for Descriptive Analytics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 10: World Recent Past, Current & Future Analysis for Predictive Analytics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 11: World 7-Year Perspective for Predictive Analytics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 12: World Recent Past, Current & Future Analysis for Prescriptive Analytics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 13: World 7-Year Perspective for Prescriptive Analytics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 14: World Recent Past, Current & Future Analysis for On-Premise by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 15: World 7-Year Perspective for On-Premise by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 16: World Recent Past, Current & Future Analysis for Cloud by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 17: World 7-Year Perspective for Cloud by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 18: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 19: World 7-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 20: World Recent Past, Current & Future Analysis for Medical Device Manufacturers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 21: World 7-Year Perspective for Medical Device Manufacturers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 22: World Recent Past, Current & Future Analysis for Research Facilities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 23: World 7-Year Perspective for Research Facilities by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 24: World Recent Past, Current & Future Analysis for Third-Party Administrators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 25: World 7-Year Perspective for Third-Party Administrators by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Life Science Analytics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • Table 26: USA Recent Past, Current & Future Analysis for Life Science Analytics by Type - Descriptive Analytics, Predictive Analytics and Prescriptive Analytics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 27: USA 7-Year Perspective for Life Science Analytics by Type - Percentage Breakdown of Value Sales for Descriptive Analytics, Predictive Analytics and Prescriptive Analytics for the Years 2024 & 2030
  • Table 28: USA Recent Past, Current & Future Analysis for Life Science Analytics by Offering - Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 29: USA 7-Year Perspective for Life Science Analytics by Offering - Percentage Breakdown of Value Sales for Services and Software for the Years 2024 & 2030
  • Table 30: USA Recent Past, Current & Future Analysis for Life Science Analytics by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 31: USA 7-Year Perspective for Life Science Analytics by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2024 & 2030
  • Table 32: USA Recent Past, Current & Future Analysis for Life Science Analytics by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 33: USA 7-Year Perspective for Life Science Analytics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators for the Years 2024 & 2030
CANADA
  • Table 34: Canada Recent Past, Current & Future Analysis for Life Science Analytics by Type - Descriptive Analytics, Predictive Analytics and Prescriptive Analytics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 35: Canada 7-Year Perspective for Life Science Analytics by Type - Percentage Breakdown of Value Sales for Descriptive Analytics, Predictive Analytics and Prescriptive Analytics for the Years 2024 & 2030
  • Table 36: Canada Recent Past, Current & Future Analysis for Life Science Analytics by Offering - Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 37: Canada 7-Year Perspective for Life Science Analytics by Offering - Percentage Breakdown of Value Sales for Services and Software for the Years 2024 & 2030
  • Table 38: Canada Recent Past, Current & Future Analysis for Life Science Analytics by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 39: Canada 7-Year Perspective for Life Science Analytics by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2024 & 2030
  • Table 40: Canada Recent Past, Current & Future Analysis for Life Science Analytics by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 41: Canada 7-Year Perspective for Life Science Analytics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators for the Years 2024 & 2030
JAPAN
  • Life Science Analytics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • Table 42: Japan Recent Past, Current & Future Analysis for Life Science Analytics by Type - Descriptive Analytics, Predictive Analytics and Prescriptive Analytics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 43: Japan 7-Year Perspective for Life Science Analytics by Type - Percentage Breakdown of Value Sales for Descriptive Analytics, Predictive Analytics and Prescriptive Analytics for the Years 2024 & 2030
  • Table 44: Japan Recent Past, Current & Future Analysis for Life Science Analytics by Offering - Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 45: Japan 7-Year Perspective for Life Science Analytics by Offering - Percentage Breakdown of Value Sales for Services and Software for the Years 2024 & 2030
  • Table 46: Japan Recent Past, Current & Future Analysis for Life Science Analytics by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 47: Japan 7-Year Perspective for Life Science Analytics by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2024 & 2030
  • Table 48: Japan Recent Past, Current & Future Analysis for Life Science Analytics by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 49: Japan 7-Year Perspective for Life Science Analytics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators for the Years 2024 & 2030
CHINA
  • Life Science Analytics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • Table 50: China Recent Past, Current & Future Analysis for Life Science Analytics by Type - Descriptive Analytics, Predictive Analytics and Prescriptive Analytics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 51: China 7-Year Perspective for Life Science Analytics by Type - Percentage Breakdown of Value Sales for Descriptive Analytics, Predictive Analytics and Prescriptive Analytics for the Years 2024 & 2030
  • Table 52: China Recent Past, Current & Future Analysis for Life Science Analytics by Offering - Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 53: China 7-Year Perspective for Life Science Analytics by Offering - Percentage Breakdown of Value Sales for Services and Software for the Years 2024 & 2030
  • Table 54: China Recent Past, Current & Future Analysis for Life Science Analytics by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 55: China 7-Year Perspective for Life Science Analytics by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2024 & 2030
  • Table 56: China Recent Past, Current & Future Analysis for Life Science Analytics by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 57: China 7-Year Perspective for Life Science Analytics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators for the Years 2024 & 2030
EUROPE
  • Life Science Analytics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • Table 58: Europe Recent Past, Current & Future Analysis for Life Science Analytics by Type - Descriptive Analytics, Predictive Analytics and Prescriptive Analytics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 59: Europe 7-Year Perspective for Life Science Analytics by Type - Percentage Breakdown of Value Sales for Descriptive Analytics, Predictive Analytics and Prescriptive Analytics for the Years 2024 & 2030
  • Table 60: Europe Recent Past, Current & Future Analysis for Life Science Analytics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 61: Europe 7-Year Perspective for Life Science Analytics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
  • Table 62: Europe Recent Past, Current & Future Analysis for Life Science Analytics by Offering - Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 63: Europe 7-Year Perspective for Life Science Analytics by Offering - Percentage Breakdown of Value Sales for Services and Software for the Years 2024 & 2030
  • Table 64: Europe Recent Past, Current & Future Analysis for Life Science Analytics by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 65: Europe 7-Year Perspective for Life Science Analytics by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2024 & 2030
  • Table 66: Europe Recent Past, Current & Future Analysis for Life Science Analytics by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 67: Europe 7-Year Perspective for Life Science Analytics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators for the Years 2024 & 2030
FRANCE
  • Life Science Analytics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • Table 68: France Recent Past, Current & Future Analysis for Life Science Analytics by Type - Descriptive Analytics, Predictive Analytics and Prescriptive Analytics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 69: France 7-Year Perspective for Life Science Analytics by Type - Percentage Breakdown of Value Sales for Descriptive Analytics, Predictive Analytics and Prescriptive Analytics for the Years 2024 & 2030
  • Table 70: France Recent Past, Current & Future Analysis for Life Science Analytics by Offering - Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 71: France 7-Year Perspective for Life Science Analytics by Offering - Percentage Breakdown of Value Sales for Services and Software for the Years 2024 & 2030
  • Table 72: France Recent Past, Current & Future Analysis for Life Science Analytics by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 73: France 7-Year Perspective for Life Science Analytics by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2024 & 2030
  • Table 74: France Recent Past, Current & Future Analysis for Life Science Analytics by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 75: France 7-Year Perspective for Life Science Analytics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators for the Years 2024 & 2030
GERMANY
  • Life Science Analytics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • Table 76: Germany Recent Past, Current & Future Analysis for Life Science Analytics by Type - Descriptive Analytics, Predictive Analytics and Prescriptive Analytics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 77: Germany 7-Year Perspective for Life Science Analytics by Type - Percentage Breakdown of Value Sales for Descriptive Analytics, Predictive Analytics and Prescriptive Analytics for the Years 2024 & 2030
  • Table 78: Germany Recent Past, Current & Future Analysis for Life Science Analytics by Offering - Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 79: Germany 7-Year Perspective for Life Science Analytics by Offering - Percentage Breakdown of Value Sales for Services and Software for the Years 2024 & 2030
  • Table 80: Germany Recent Past, Current & Future Analysis for Life Science Analytics by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 81: Germany 7-Year Perspective for Life Science Analytics by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2024 & 2030
  • Table 82: Germany Recent Past, Current & Future Analysis for Life Science Analytics by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 83: Germany 7-Year Perspective for Life Science Analytics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators for the Years 2024 & 2030
ITALY
  • Table 84: Italy Recent Past, Current & Future Analysis for Life Science Analytics by Type - Descriptive Analytics, Predictive Analytics and Prescriptive Analytics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 85: Italy 7-Year Perspective for Life Science Analytics by Type - Percentage Breakdown of Value Sales for Descriptive Analytics, Predictive Analytics and Prescriptive Analytics for the Years 2024 & 2030
  • Table 86: Italy Recent Past, Current & Future Analysis for Life Science Analytics by Offering - Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 87: Italy 7-Year Perspective for Life Science Analytics by Offering - Percentage Breakdown of Value Sales for Services and Software for the Years 2024 & 2030
  • Table 88: Italy Recent Past, Current & Future Analysis for Life Science Analytics by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 89: Italy 7-Year Perspective for Life Science Analytics by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2024 & 2030
  • Table 90: Italy Recent Past, Current & Future Analysis for Life Science Analytics by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 91: Italy 7-Year Perspective for Life Science Analytics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators for the Years 2024 & 2030
UNITED KINGDOM
  • Life Science Analytics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • Table 92: UK Recent Past, Current & Future Analysis for Life Science Analytics by Type - Descriptive Analytics, Predictive Analytics and Prescriptive Analytics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 93: UK 7-Year Perspective for Life Science Analytics by Type - Percentage Breakdown of Value Sales for Descriptive Analytics, Predictive Analytics and Prescriptive Analytics for the Years 2024 & 2030
  • Table 94: UK Recent Past, Current & Future Analysis for Life Science Analytics by Offering - Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 95: UK 7-Year Perspective for Life Science Analytics by Offering - Percentage Breakdown of Value Sales for Services and Software for the Years 2024 & 2030
  • Table 96: UK Recent Past, Current & Future Analysis for Life Science Analytics by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 97: UK 7-Year Perspective for Life Science Analytics by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2024 & 2030
  • Table 98: UK Recent Past, Current & Future Analysis for Life Science Analytics by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 99: UK 7-Year Perspective for Life Science Analytics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators for the Years 2024 & 2030
REST OF EUROPE
  • Table 100: Rest of Europe Recent Past, Current & Future Analysis for Life Science Analytics by Type - Descriptive Analytics, Predictive Analytics and Prescriptive Analytics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 101: Rest of Europe 7-Year Perspective for Life Science Analytics by Type - Percentage Breakdown of Value Sales for Descriptive Analytics, Predictive Analytics and Prescriptive Analytics for the Years 2024 & 2030
  • Table 102: Rest of Europe Recent Past, Current & Future Analysis for Life Science Analytics by Offering - Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 103: Rest of Europe 7-Year Perspective for Life Science Analytics by Offering - Percentage Breakdown of Value Sales for Services and Software for the Years 2024 & 2030
  • Table 104: Rest of Europe Recent Past, Current & Future Analysis for Life Science Analytics by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 105: Rest of Europe 7-Year Perspective for Life Science Analytics by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2024 & 2030
  • Table 106: Rest of Europe Recent Past, Current & Future Analysis for Life Science Analytics by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 107: Rest of Europe 7-Year Perspective for Life Science Analytics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators for the Years 2024 & 2030
ASIA-PACIFIC
  • Life Science Analytics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • Table 108: Asia-Pacific Recent Past, Current & Future Analysis for Life Science Analytics by Type - Descriptive Analytics, Predictive Analytics and Prescriptive Analytics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 109: Asia-Pacific 7-Year Perspective for Life Science Analytics by Type - Percentage Breakdown of Value Sales for Descriptive Analytics, Predictive Analytics and Prescriptive Analytics for the Years 2024 & 2030
  • Table 110: Asia-Pacific Recent Past, Current & Future Analysis for Life Science Analytics by Offering - Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 111: Asia-Pacific 7-Year Perspective for Life Science Analytics by Offering - Percentage Breakdown of Value Sales for Services and Software for the Years 2024 & 2030
  • Table 112: Asia-Pacific Recent Past, Current & Future Analysis for Life Science Analytics by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 113: Asia-Pacific 7-Year Perspective for Life Science Analytics by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2024 & 2030
  • Table 114: Asia-Pacific Recent Past, Current & Future Analysis for Life Science Analytics by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 115: Asia-Pacific 7-Year Perspective for Life Science Analytics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators for the Years 2024 & 2030
REST OF WORLD
  • Table 116: Rest of World Recent Past, Current & Future Analysis for Life Science Analytics by Type - Descriptive Analytics, Predictive Analytics and Prescriptive Analytics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 117: Rest of World 7-Year Perspective for Life Science Analytics by Type - Percentage Breakdown of Value Sales for Descriptive Analytics, Predictive Analytics and Prescriptive Analytics for the Years 2024 & 2030
  • Table 118: Rest of World Recent Past, Current & Future Analysis for Life Science Analytics by Offering - Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 119: Rest of World 7-Year Perspective for Life Science Analytics by Offering - Percentage Breakdown of Value Sales for Services and Software for the Years 2024 & 2030
  • Table 120: Rest of World Recent Past, Current & Future Analysis for Life Science Analytics by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 121: Rest of World 7-Year Perspective for Life Science Analytics by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2024 & 2030
  • Table 122: Rest of World Recent Past, Current & Future Analysis for Life Science Analytics by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 123: Rest of World 7-Year Perspective for Life Science Analytics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators for the Years 2024 & 2030
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Accenture PLC
  • Cognizant Technology Solutions Corporation
  • IBM Corporation
  • IQVIA
  • MaxisIT Inc.
  • Oracle Corporation
  • SAS Institute, Inc.
  • SCIO Health Analytics, an EXL company
  • TAKE Solutions
  • Wipro Ltd.

Table Information